Cambodia’s pharmaceutical sector, once limited by state ownership and underdeveloped infrastructure, is now witnessing gradual modernization in response to rising healthcare demands and regional integration. This case study examines the transformation of Santelys Pharmaceutical Co., Ltd., formerly Cambodia Pharmaceutical Enterprise, the nation’s first pharmaceutical manufacturer, established through Chinese government aid. Following Cambodia’s broader economic liberalization, the enterprise underwent privatization and was restructured in 2019 as Santelys, a certified GMP manufacturing facility built to EU PIC/S standards. Drawing on qualitative interview and documentary analysis, the study investigates how the company navigated institutional transition, regulatory adaptation, and quality certification. Key themes include strategic leadership, international collaboration, and mission-driven value creation. The case provides critical insights into pharmaceutical entrepreneurship in resource-constrained contexts and contributes to discourse on industrial upgrading, privatization, and innovation-led growth in emerging health systems.
Akbar, H., & Zaman, S. U. (2025). Innovation Dynamic Performance in the Pharmaceutical Industry: A Study on Establishing a Generic Strategic Planning. Journal of Business and Management Research, 4(2), 95-131.
Chataway, J., Tait, J., & Wield, D. (2007). Frameworks for pharmaceutical innovation in developing countries—the case of Indian pharma. Technology Analysis & Strategic Management, 19(5), 697-708.
Department of Drugs and Food in Cambodia. (2012). Pharmaceutical sector strategic plan 2013-2018. Ministry of Health. Availableat: https://www.haiasiapacific.org/wp-content/uploads/2015/02/CambodiaPSSP2013-2018FinalDraftOct2012 .pdf (Retreived on 20 June 2025)
National Institute of Statistics. (2020). Cambodia Demographic and Health Survey 2021-22. National Institute of Statistics. Available at: https://dhsprogram.com/pubs/pdf/FR377/FR377.pdf (Retrieved on 20 June 2025)
Sengxeu, N., Aon, C., Dufat, H., Boumediene, F., Chan, S., Ros, S., ... & Jost, J. (2021). Availability, affordability, and quality of essential anti?seizure medication in Cambodia. Epilepsia Open, 6(3), 548-558.
United Nations. (2024). Cambodia graduation status. United Nations. Available at: https://www.un.org/ldcportal/content/cambodia-graduation-status (Retrieved on 24 June 2025)
Vieira, M., Andia, T., Karim, O., Srishti, S. A., Pineda, S. A., Alonso Ruiz, A., ... & Ahmed, S. M. (2023). Rising pharmaceutical innovation in the Global South: a landscape study. Journal of Pharmaceutical Policy and Practice, 16(1), 155.
World Bank. (2025). The world Bank in Cambodia. World Bank Group. Available at: https://www.worldbank.org/en/country/cambodia (Retrieved on 20 June 2025) complete list of all references cited in the paper
Hong, G., Teo, P.-C., & Yue, S. (2026). Building Health Industries in Emerging Economies: The Case of Santelys Pharmaceutical in Cambodia. International Journal of Academic Research in Business and Social Sciences, 16(2), 896–900.
Copyright: © 2026 The Author(s)
Published by Knowledge Words Publications (www.kwpublications.com)
This article is published under the Creative Commons Attribution (CC BY 4.0) license. Anyone may reproduce, distribute, translate and create derivative works of this article (for both commercial and non-commercial purposes), subject to full attribution to the original publication and authors. The full terms of this license may be seen at: http://creativecommons.org/licences/by/4.0/legalcode
